孔雨 - 天津医科大学

个人简介

教育背景 2011/09-2014/06，山东大学，生命科学学院发育生物学系，硕士 2007/09-2011/06，山东大学，生命科学学院生物科学专业，学士工作经历 2014/08-至今，天津医科大学，基础医学院细胞生物学系，助理实验师

研究领域

肿瘤表观遗传

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

(1) Yu Kong#, Chunbo Ai, Feng Dong, Xianyou Xia, Xiujuan Zhao, Chao Yang, Chunsheng Kang, Yan Zhou, Qian Zhao*, Xiujing Sun*, Xudong Wu*. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. Cell Cycle. 2018,17(10):1199-1211. (2) Feng Dong#, Qian Li#, Chao Yang#, Dawei Huo, Xing Wang, Chunbo Ai, Yu Kong, Xiaoyu Sun, Wen Wang, Yan Zhou, Xing Liu, Wei Li, Weiwei Gao, Wen Liu, Chunsheng Kang* & Xudong Wu*, PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma, Nature Communications, 2018:9:4552. (3) Xiujuan Zhao#, Xing Wang, Qian Li, Wanbiao Chen, Na Zhang, Yu Kong, Junqiang Lv, Lei Cao, Dan Lin, Xi Wang, Guogang Xu*, Xudong Wu*. FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway. 2018,9:46. (4) Guoying Zheng#, Binbin Guan#, Penghui Hu, Xingying Qi, Pingting Wang, Yu Kong, Zihao Liu, Ping Gao, Rui Li, Xu Zhang, Xudong Wu*, Lei Sui*.Topographical cues of direct metal laser sintering titanium surfaces facilitate osteogenic differentiation of bone marrow mesenchymal stem cells through epigenetic regulation. Cell Proliferation. 2018,e12460. (5) Wu X#*, Bekker-Jensen IH, Christensen J, Rasmussen KD, Sidoli S, Qi Y, Kong Y, Wang X, Cui Y, Xiao Z, Xu G, Williams K,Rappsilber J, Sønderby CK, Winther O, Jensen ON, Helin K*, Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals, Cell Research, (2015) :1-14 (6) Jie Yan#, Xuan Dong, Yu Kong, Lijun Feng*, Identification and primary immune characteristics of an amphioxus akirin homolog, Fish Shellfish Immun, 35 (2013): 564-57 (7) Yan Zhang#, Haiqing Zhang, Yu Kong, Lijun Feng*, Identiﬁcation and characterization of an amphioxus matrix metalloproteinase homolog BbMMPL2 responding to bacteria challenge, Dev, Comp, Immunol, 37(2012): 371-380